Previous most cancers historical past not linked with elevated mortality or hospitalization attributable to COVID-19

Sufferers recognized with most cancers a couple of yr in the past and people not receiving energetic remedy have been no extra weak to worse COVID-19 outcomes than sufferers with out most cancers, in accordance with a brand new research led by UTHealth Houston.

Youngran Kim, PhD, and Liang Zhu, PhD, researchers within the Division of Neurology with McGovern Medical College at UTHealth Houston, have been co-leading authors of the research, which was printed as we speak in PLOS ONE. Kim, a postdoctoral analysis fellow within the division, is presently an assistant professor within the Division of Administration, Coverage, and Neighborhood Well being with UTHealth College of Public Well being, and Zhu, a former affiliate professor of neurology, has since left UTHealth Houston.

Utilizing digital well being data from greater than 700 hospitals and 700 clinics within the U.S., a group of researchers with UTHealth Houston, Baylor School of Medication, the College of Kentucky, and The College of Texas MD Anderson Most cancers Heart collaborated to evaluate the affiliation between COVID-19 outcomes and present cancer-specific traits.

Many research have proven that folks with most cancers have increased dangers for demise and hospitalization after being recognized with COVID-19 in comparison with sufferers with out most cancers, however Kim mentioned the revelation concerning the timing of the sufferers’ previous most cancers prognosis and ongoing remedy state is essential.

We discovered that latest most cancers diagnoses have been related to a 17% elevated threat for demise and 10% elevated threat for hospitalization. Nonetheless, a historical past of most cancers a couple of yr earlier than COVID-19 prognosis was not considerably related to elevated mortality or hospitalization. Our research additionally confirmed different threat components and racial disparities in COVID-19 outcomes amongst COVID-19 sufferers with most cancers.”

Youngran Kim, PhD, Researcher, Division of Neurology, McGovern Medical College, UTHealth Houston

The researchers analyzed 271,639 grownup sufferers recognized with COVID-19 between June 1, 2020 and Dec. 31, 2020. Of these sufferers, 18,460 additionally had no less than one most cancers prognosis, together with 10,426 sufferers recognized with most cancers inside one yr earlier than their COVID-19 an infection.

A number of outcomes have been assessed, together with all-cause 30-day mortality, hospitalization, admission to the intensive care unit (ICU), and ventilator use, which have been in contrast utilizing relative dangers in accordance with most cancers standing and coverings. Among the many analysis group’s key discoveries:

  • Whereas most cancers sufferers had increased dangers for 30-day mortality and hospitalization, there have been no important variations in ICU admission and ventilator use in comparison with sufferers with out most cancers.
  • Current most cancers diagnoses have been related to increased dangers for worse COVID-19 outcomes, significantly amongst latest metastatic (stage 4), hematological, liver, and lung cancers, in comparison with the non-cancer group.
  • Amongst COVID-19 sufferers with a latest most cancers prognosis, a better probability of mortality was linked to chemotherapy or radiation remedies inside three months earlier than SARS-CoV-2 an infection.
  • Sufferers who have been older, Black, obtained Medicare, and/or lived within the Southern U.S. have been considerably extra more likely to die after SARS-CoV-2 an infection.
  • Diabetes and cardiovascular, liver, and renal illnesses have been additionally linked to an elevated threat of demise after SARS-CoV-2 an infection.

Research investigators hope these findings will supply well being care suppliers extra refined threat details about the methods most cancers sufferers could also be impacted by COVID-19.

UTHealth Houston co-authors with the Division of Neurology at McGovern Medical College included Xiaojin Li, PhD; Yan Huang, PhD; and Chunhui Gu, MS. Guo-Qiang “GQ” Zhang, PhD, professor within the division with secondary appointments at UTHealth Houston College of Biomedical Informatics and UTHealth College of Public Well being, was the research group lead and corresponding creator on the publication. Zhang can also be vice chairman and chief knowledge scientist for UTHealth Houston.

“Most scientific literature publishes affirmative outcomes,” Zhang mentioned. “On this specific research, we not solely confirmed basic findings about worse COVID-19 outcomes for most cancers sufferers, however elaborated on subgroups of most cancers sufferers that weren’t overly impacted. This is a crucial discovering for the well being care system as they intervene based mostly on the suitable threat evaluation and for most cancers survivors to grasp their particular dangers related to COVID-19. Because the pandemic evolves, nonetheless, we might must revisit this matter at a future time.”

Different co-authors included Huili Zhu, MD, with Baylor School of Medication; Heather Bush, PhD, with the College of Kentucky in Lexington; and Caroline Chung, MD, with MD Anderson.


Journal reference:

Kim, Y., et al. (2022) Characterizing most cancers and COVID-19 outcomes utilizing digital well being data. PLOS ONE.

Supply hyperlink

Leave a Comment

%d bloggers like this: